Minoryx Therapeutics today announces 24-week interim results from NEXUS. This open label registration-enabling clinical trial is assessing the safety and efficacy of lead candidate leriglitazone, a no...
Read more
Scientists from CiQUS, ICN2, University of Cantabria, DIPC and DTU join forces to develop a versatile method for building brick by brick carbon nanocircuits with tunable properties.
Read more
One of the most promising strategies against cancer, on which most research efforts are being focused, is the use of modified viruses. Viruses are used in this case as immunotherapy agents, to stimula...
Read more
Se identificó a un grupo de pacientes que presentaban una ‘tormenta vírica’, caracterizada por la liberación masiva de ácido ribonucleico (ARN) y proteínas del SARS-CoV-2 en sangre, y que, a ...
Read more
Un estudio en el que han participado equipos de las áreas CIBER de Enfermedades Infecciosas (CIBERINFEC) y de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBNse ha centrado en determinar media...
Read more
Se trata de uno de los primeros grupos multidisciplinares de España especializados en esta enfermedad minoritaria sistémica, que puede provocar un gran número de síntomas
Read more
A study by the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) with the Arctic University of Norway compares the effect of two treatments on the alterations in m...
Read more
Research conducted in Lleida has discovered a new link between intracellular calcium, signalling pathways and autophagy that represents a new advance in preventing alterations in the process of cell d...
Read more
An international consortium aims to address this challenge by developing the new PLAST_CELL technology platform that can quantitatively assess tumor plasticity at the single cell level.
Read more
The pioneering artificial cornea designed and generated from biomaterials and stem cells by scientists from Granada has successfully passed its first clinical trial in humans, and has made it possible...
Read more
Abyntek Biopharma, through its Corporate Social Responsibility program "We finance your project", materializes its commitment to oncology research by allocating resources to finance and facilitate the...
Read moreSparingVision, a clinical-stage genomic medicine company developing vision-saving treatments for ocular diseases, shares progress in its lead gene therapy program, SPVN06, and research on retinitis pi...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
